(CGEM) Cullinan Oncology - Performance -51.7% in 12m
CGEM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-74.16%
#112 in Peer-Group
Rel. Strength
8.55%
#7041 in Stock-Universe
Total Return 12m
-51.67%
#136 in Peer-Group
Total Return 5y
-73.92%
#88 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 6.30 |
| High / Low | USD |
|---|---|
| 52 Week High | 20.86 USD |
| 52 Week Low | 7.13 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 57.03 |
| Buy/Sell Signal +-5 | 1.72 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CGEM (-51.7%) vs XBI (-6.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.92% | 72.5% | 80.4% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.48% | -6.85% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.26% | -3.11% | 38.6% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.07% | 32.1% | -2.24% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.19% | -6.83% | 5.89% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.6% | 39.2% | -5% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.71% | 54.5% | -7.69% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.98% | 29.3% | 17.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CGEM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CGEM
| Total Return (including Dividends) | CGEM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -10.96% | 4.28% | 4.37% |
| 3 Months | 0.13% | 17.36% | 14.09% |
| 12 Months | -51.67% | -6.86% | 13.68% |
| 5 Years | -73.92% | -21.19% | 112.88% |
| Trend Score (consistency of price movement) | CGEM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -80.4% | 13.1% | 83.6% |
| 3 Months | 6.2% | 79.4% | 97.2% |
| 12 Months | -93.9% | -87.1% | 45.7% |
| 5 Years | -55.8% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th22.00 | -14.61% | -14.69% |
| 3 Month | %th24.00 | -14.68% | -12.24% |
| 12 Month | %th32.00 | -48.11% | -57.49% |
| 5 Years | %th63.50 | -55.71% | -85.04% |
FAQs
Does Cullinan Oncology (CGEM) outperform the market?
No,
over the last 12 months CGEM made -51.67%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.86%.
Over the last 3 months CGEM made 0.13%, while XBI made 17.36%.
Performance Comparison CGEM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CGEM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.1% | -15.3% | -38.4% | -65% |
| US NASDAQ 100 | QQQ | -0.5% | -15.9% | -40.3% | -64% |
| German DAX 40 | DAX | -2.7% | -12.6% | -51.3% | -86% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.8% | -14.5% | -42.1% | -72% |
| Hongkong Hang Seng | HSI | 1.4% | -14.1% | -58.9% | -90% |
| India NIFTY 50 | INDA | 0.4% | -11.7% | -39% | -50% |
| Brasil Bovespa | EWZ | 3.1% | -14.8% | -56.7% | -56% |
CGEM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.9% | -14.7% | -42.6% | -76% |
| Consumer Discretionary | XLY | 1% | -13.6% | -29.9% | -68% |
| Consumer Staples | XLP | 2.2% | -10.7% | -37.5% | -59% |
| Energy | XLE | -0.8% | -17.2% | -31.5% | -54% |
| Financial | XLF | 0.9% | -14.1% | -41.8% | -79% |
| Health Care | XLV | 0.4% | -12.4% | -28.2% | -47% |
| Industrial | XLI | -0.7% | -14.8% | -45.1% | -78% |
| Materials | XLB | 0.1% | -15.4% | -41.6% | -59% |
| Real Estate | XLRE | 1.4% | -10.8% | -37.6% | -63% |
| Technology | XLK | -1.1% | -18.8% | -43.4% | -62% |
| Utilities | XLU | -0.3% | -13.2% | -40.2% | -74% |
| Aerospace & Defense | XAR | -1.2% | -15.6% | -57% | -102% |
| Biotech | XBI | -3.1% | -15.2% | -28.6% | -45% |
| Homebuilder | XHB | -0.7% | -20.3% | -33.3% | -59% |
| Retail | XRT | 0.5% | -13% | -32.3% | -63% |
CGEM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.3% | -17.7% | -25.7% | -48% |
| Natural Gas | UNG | 8.4% | 3.3% | -7.4% | -42% |
| Gold | GLD | 1.7% | -10.6% | -53.4% | -91% |
| Silver | SLV | 1.2% | -9.8% | -49.8% | -69% |
| Copper | CPER | -5.9% | -22.8% | -57.9% | -73% |
CGEM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.3% | -13.1% | -34.2% | -50% |
| iShares High Yield Corp. Bond | HYG | 0.7% | -12.5% | -35.4% | -62% |